Comparison of Misoprostol and PGE2 Gel for Induction of Labour in Women With Premature Rupture of Membranes at Term
Induction of labour with vaginal misoprostol, in women with premature rupture of membranes at term, results in significant shortening of induction to delivery time in comparison to vaginal PGE2 gel induction...
Brief Summary
Official Title: “Comparison of Misorostol & PGE2 Gel for Immediate Induction of Labour for Premature Ropture of Membranes at Term”
Induction of labour with vaginal misoprostol, in women with premature rupture of membranes at term, results in significant shortening of induction to delivery time in comparison to vaginal PGE2 gel induction.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
- Study Primary Completion Date: September 2008
Intervention(s) in this Clinical Trial
- Drug: Misoprostol
- In one group of women immediate induction of labour will be done by intravaginal misoprostol 25 microgram 4 hourly , a maximum of 5 doses .
- Drug: PGE2 gel
- In other group immediate induction of labour will be done by intravaginal application of PGE2 gel 0.5 mg at an interval of 6 hours , a maximum of 2 doses.
Arms, Groups and Cohorts in this Clinical Trial
- Active Comparator: A
- In group A, immediate induction of labour will be done by intravaginal misoprostol 25 microgram 4 hourly , a maximum of 5 doses .
- Active Comparator: B
- In Group B immediate induction of labour will be done by application of vaginal PGE2 gel 0.5 gm at an interval of 6 hours , a maximum of 2 doses.
Outcome Measures for this Clinical Trial
Primary Measures
- Admission to delivery time
- Time Frame: 48 hours
Safety Issue?: Yes
- Time Frame: 48 hours
Secondary Measures
- Caesarean Section rate
- Time Frame: 48 hours
Safety Issue?: No
- Time Frame: 48 hours
- Neonatal morbidity
- Time Frame: Till discharge
Safety Issue?: Yes
- Time Frame: Till discharge
- Maternal morbidity
- Time Frame: Till discharge
Safety Issue?: Yes
- Time Frame: Till discharge
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Premature rupture of membranes at 37 or more weeks
- Single live fetus in cephalic presentation
Exclusion Criteria:
- Women in labour
- Women with contraindication of induction of labour
- Women with previous caesarean section or uterine surgery
Gender Eligibility for this Clinical Trial: Female
Minimum Age for this Clinical Trial: N/A
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Nilratan Sircar Medical College Other
Overall Clinical Trial Officials and Contacts
Snehamay Chaudhuri, MBBS,MD,DNB Principal Investigator NRS Medical College , Kolkata, India
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00355966
Study ID Number: 1-Chaudhuri
ClinicalTrials.gov Identifier: NCT00355966
Health Authority: India: Ministry of Health
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00355966
